NCT07047807View on ClinicalTrials.gov

PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

August 31, 2027

Conditions

PDAC - Pancreatic Ductal Adenocarcinoma

Interventions

BEHAVIORAL

PDAC-PATHWAYS

A digital app for patients initiating neoadjuvant therapy for PDAC

OTHER

Usual Care

Routine treatment

Trial Locations (1)

02114

Massachusetts General HospitaL, Boston

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Massachusetts General Hospital

OTHER

NCT07047807 - PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma | Biotech Hunter | Biotech Hunter